Your browser doesn't support javascript.
loading
Decreased eukaryotic initiation factors expression upon temozolomide treatment-potential novel implications for eIFs in glioma therapy.
Krassnig, Stefanie; Leber, Stefan L; Orthmann, Andrea; Golob-Schwarzl, Nicole; Huber, Heinrich Johann; Wohlrab, Christina; Skofler, Christina; Pennauer, Mirjam; Raicht, Andrea; Birkl-Toeglhofer, Anna Maria; Naumann, Michael; Mahdy-Ali, Kariem; von Campe, Gord; Leoni, Marlene; Alcaniz, Joshua; Hoffmann, Jens; Wälchli, Thomas; Weis, Serge; Benesch, Martin; Haybaeck, Johannes.
Afiliação
  • Krassnig S; Diagnostic & Research Center for Molecular BioMedicine, Department of Neuropathology, Institute of Pathology, Medical University of Graz, Graz, Austria.
  • Leber SL; Diagnostic & Research Center for Molecular BioMedicine, Department of Neuropathology, Institute of Pathology, Medical University of Graz, Graz, Austria.
  • Orthmann A; Division of Neuroradiology, Vascular & Interventional Radiology, Department of Radiology, Medical University of Graz, Auenbruggerplatz 9, Graz, 8036, Austria.
  • Golob-Schwarzl N; EPO Berlin Buch GmbH, Berlin, Germany.
  • Huber HJ; Diagnostic & Research Center for Molecular BioMedicine, Department of Neuropathology, Institute of Pathology, Medical University of Graz, Graz, Austria.
  • Wohlrab C; Center for Biomarker Research in Medicine, Graz, Austria.
  • Skofler C; Drug Discovery Sciences, Dr. Boehringer Gasse 5-11 A-1121, Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
  • Pennauer M; Diagnostic & Research Center for Molecular BioMedicine, Department of Neuropathology, Institute of Pathology, Medical University of Graz, Graz, Austria.
  • Raicht A; Diagnostic & Research Center for Molecular BioMedicine, Department of Neuropathology, Institute of Pathology, Medical University of Graz, Graz, Austria.
  • Birkl-Toeglhofer AM; Center for Biomarker Research in Medicine, Graz, Austria.
  • Naumann M; Diagnostic & Research Center for Molecular BioMedicine, Department of Neuropathology, Institute of Pathology, Medical University of Graz, Graz, Austria.
  • Mahdy-Ali K; Division of Paediatric Haematology and Oncology, Department of Paediatrics and Adolescent Medicine, Medical University of Graz, Graz, Austria.
  • von Campe G; Diagnostic & Research Center for Molecular BioMedicine, Department of Neuropathology, Institute of Pathology, Medical University of Graz, Graz, Austria.
  • Leoni M; Department of Pathology, Medical University of Innsbruck, Müllerstraße 44, Innsbruck, 6020, Austria.
  • Alcaniz J; Institute of Experimental Internal Medicine, Otto Von Guericke University, Magdeburg, Germany.
  • Hoffmann J; Department of Neurosurgery, Medical University of Graz, Graz, Austria.
  • Wälchli T; Department of Neurosurgery, Medical University of Graz, Graz, Austria.
  • Weis S; Diagnostic & Research Center for Molecular BioMedicine, Department of Neuropathology, Institute of Pathology, Medical University of Graz, Graz, Austria.
  • Benesch M; EPO Berlin Buch GmbH, Berlin, Germany.
  • Haybaeck J; EPO Berlin Buch GmbH, Berlin, Germany.
J Neurooncol ; 165(1): 91-100, 2023 Oct.
Article em En | MEDLINE | ID: mdl-37907716
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma / Glioma Limite: Humans Idioma: En Revista: J Neurooncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Áustria País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma / Glioma Limite: Humans Idioma: En Revista: J Neurooncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Áustria País de publicação: Estados Unidos